Journal profile · Materials Science, Biomaterials

EUROPEAN CELLS & MATERIALS

ISSN 1473-2262 · AO Research Institute · SWITZERLAND · Semiannual · Founded 2001

EUROPEAN CELLS & MATERIALS: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.79; fully open access; APC about USD 2,500; review about 1.5 months (community reports); community-reported acceptance: about 22.5%; 49 articles in 2025; indexed in SCIE and Scopus.

Impact factor3.79Latest value listed by LetPub
CAS zoneZone 2 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine
Review timeabout 1.5 monthsCommunity average
APCUSD 2,500Fully open access
Acceptanceabout 22.5%Community average
Articles per year492025 · OpenAlex count

Scope

Aims, scope and focus

EUROPEAN CELLS & MATERIALS is published by AO Research Institute and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bone Tissue Engineering Materials, Osteoarthritis Treatment and Mechanisms and Mesenchymal stem cell research, together about 29.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

eCM Journal (European Cells & Materials) provides a multidisciplinary high-level forum for preclinical biomedical research (Orthopaedics, Cell & tissue engineering, Biomaterials science, and Biomedical engineering). Research fields include, but are not limited to Musculoskeletal, Stem cells, Drug/gene carrier design, Bionanomedicine, and Application of biomaterials.

From the journal's Aims & Scope

Research area (LetPub): Materials Science, Biomaterials

Editor-in-chief Martin Stoddart Editor-in-ChiefPublisher website

Editorial board by country: 10 in mainland China (about 29%); most named Mainland China 10, Switzerland 8, Germany 3, Netherlands 3, United States 2 (35 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Bone Tissue Engineering MaterialsEngineering11.3%
  2. Osteoarthritis Treatment and MechanismsMedicine10.9%
  3. Mesenchymal stem cell researchMedicine7.2%
  4. Periodontal Regeneration and TreatmentsMedicine6.7%
  5. Spine and Intervertebral Disc PathologyMedicine6.4%
  6. Orthopaedic implants and arthroplastyMedicine5.5%
  7. Tissue Engineering and Regenerative MedicineMedicine4.9%
  8. Bone fractures and treatmentsMedicine4.5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorCell & Tissue EngineeringZone 2
MinorEngineering, BiomedicalZone 2
MinorMaterials Science, BiomaterialsZone 2
MinorOrthopedicsZone 2

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorCell & Tissue EngineeringZone 2
MinorEngineering, BiomedicalZone 2
MinorMaterials Science, BiomaterialsZone 2
MinorOrthopedicsZone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorCell & Tissue EngineeringZone 3
MinorEngineering, BiomedicalZone 3
MinorMaterials Science, BiomaterialsZone 3
MinorOrthopedicsZone 3

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

Web of SciencePublisher website

Other: ISSN

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
3.79LetPub ·
Impact factor (publisher) 2025
3.6Publisher website ·
5-year impact factor (publisher)
3.5Publisher website ·
CiteScore 2026-06
4LetPub ·
SJR 2026-06
0.68LetPub ·
SNIP 2026-06
0.79LetPub ·
h-index
73LetPub ·
h-index
109OpenAlex ·
i10-index
759OpenAlex ·
2-year mean citedness
6.4OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
45LetPub ·

Articles by year OpenAlex count · 969 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026363622
20254949420
20242828281
20232020220
20223131382
202181811,488

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 1.5 monthsLetPub ·
Average acceptance (community reports)
22.5%LetPub ·
Submission to publication (journal-reported)
about 28 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 2,500YesCC BY
OpenAlexUSD 1,000——
LetPubUSD 1,000No—
Publisher websiteUSD 2,500——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Policy excerpts from the journal's websiteOpen access
Open access

Open Access Model summary

Open Access: Article Processing Charge: USD 2,500 (excluding taxes).

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
AO Research Institute
Country or region
SWITZERLAND
Language
English
Frequency
Semiannual
Founded
2001
ISSN
1473-2262
Official links

FAQ

Frequently asked questions about EUROPEAN CELLS & MATERIALS

What CAS zone is EUROPEAN CELLS & MATERIALS in?

In the 2025 upgraded edition of the CAS Journal Ranking, EUROPEAN CELLS & MATERIALS is in Zone 2 of Medicine, and in Zone 2 of the minor category Cell & Tissue Engineering / Engineering, Biomedical / Materials Science, Biomaterials / Orthopedics. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of EUROPEAN CELLS & MATERIALS?

The latest impact factor listed by LetPub is 3.79; CiteScore 4, h-index 109.

How long does peer review take at EUROPEAN CELLS & MATERIALS?

Authors report an average review time of about 1.5 months; the community-reported acceptance is “about 22.5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of EUROPEAN CELLS & MATERIALS based?

Of the 35 board members whose country the journal's board page names, 10 (about 29%) are in mainland China; the countries named most often are Mainland China (10), Switzerland (8) and Germany (3). Counted from the institutions listed on the board page; for reference only.

Which databases index EUROPEAN CELLS & MATERIALS?

According to LetPub and DOAJ records, EUROPEAN CELLS & MATERIALS is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science; that list has not been checked against each database.

Is EUROPEAN CELLS & MATERIALS open access, and what is the APC?

EUROPEAN CELLS & MATERIALS is a fully open-access journal. APC about USD 2,500.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .